KRAS and neoplasm: In addition, as discussed earlier, KRAS controls major signaling pathways involved in tumorigenesis, highlighting the need to understand the clinical impact of mutated KRAS on cancer development and progression, as well as potential differences in prevalence and KRAS-related molecular heterogeneity across tumor types.